Biochemical and hormonal abnormalities in adult female acne

被引:3
|
作者
Meena, Amit Kumar [1 ]
Mendiratta, Vibhu [1 ]
Goyal, Rajeev [2 ]
Bisherwal, Kavita [1 ]
Yadav, Vidya [1 ]
Prasadh, Vivin [1 ]
机构
[1] Lady Hardinge Med Coll & Hosp, Dept Dermatol & STD, RZ-146, New Delhi 110001, India
[2] Lady Hardinge Med Coll & Hosp, Dept Biochem, New Delhi, India
关键词
adult female acne; fasting blood glucose; homeostasis model assessment of insulin resistance; lipid profile; serum insulin; LESION COUNTS; WOMEN; PROFILE;
D O I
10.1111/jocd.15588
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BackgroundPrevalence of adult patients with acne is increasing and women comprise majority of the cases. There is lack of data on biochemical and hormonal abnormalities in adult female acne (AFA). AimsTo evaluate biochemical and hormonal parameters in 60 patients of AFA. MethodsA cross-sectional observational study conducted from November 2018 to March 2020 in Dermatology outpatient department of a tertiary care hospital in North India. Adult females (age > 25 years) with a clinical diagnosis of acne were included in the study. Results60 cases of AFA were included. The age ranged between 26-41 years with mean age at presentation being 29.45 years. 53.3% patients had persistent acne while 46.7% had late-onset acne. 50% patients had history of premenstrual flare-up of their acne. Raised FBG was found in 25% patients. 10% had raised serum insulin levels. HOMA-IR index was deranged in 55% patients. At least one lipid alteration was reported in 91.6% of patients. In hormonal parameters, raised TT was present in 6.7%, LH in 3.3%, FSH in 18.3%, prolactin in 3.3%, and TSH in 15%. No association was found between acne severity and biochemical and hormonal parameters. ConclusionsOur study highlighted the importance of measuring lipid profile in AFA and calculating HOMA-IR index for measuring insulin resistance rather than simply measuring serum insulin levels. In our study, additional parameter deranged in significant number of patients was FBG. Hence, we recommend routine screening of lipid profile, FBG and calculation of HOMA-IR index in AFA.
引用
收藏
页码:1392 / 1399
页数:8
相关论文
共 50 条
  • [1] A prospective study examining trigger factors and hormonal abnormalities in adult female acne
    Bansal, Prekshi
    Sardana, Kabir
    Vats, Gauri
    Sharma, Lokesh
    Garga, Umesh Chandra
    Khurana, Ananta
    INDIAN DERMATOLOGY ONLINE JOURNAL, 2020, 11 (04) : 544 - 550
  • [2] Management of acne vulgaris with hormonal therapies in adult female patients
    Husein-ElAhmed, Husein
    DERMATOLOGIC THERAPY, 2015, 28 (03) : 166 - 172
  • [3] Spironolactone for Adult Female Acne
    Friedman, Adam J.
    CUTIS, 2015, 96 (04): : 216 - 217
  • [4] Hormonal female dermatoses II Acne sexualis
    von Leszczynski, R
    Liebhart, S
    DERMATOLOGISCHE WOCHENSCHRIFT, 1932, 94 (1/26): : 261 - 272
  • [5] FEATURE AFFECTIVE DISORDERS ON WOMEN WITH ACNE AND HORMONAL ABNORMALITIES
    Golousenko, I. Y.
    Olkhovskaya, K. B.
    ACTA DERMATO-VENEREOLOGICA, 2016, 96 : 136 - 136
  • [6] Adult Female Acne Azelaic Acid in the Treatment of Acne in Adult Females Introduction
    Bagatin, E.
    SKIN PHARMACOLOGY AND PHYSIOLOGY, 2014, 27 : 1 - 2
  • [7] Adult female acne: a new paradigm
    Dreno, B.
    Layton, A.
    Zouboulis, C. C.
    Lopez-Estebaranz, J. L.
    Zalewska-Janowska, A.
    Bagatin, E.
    Zampeli, V. A.
    Yutskovskaya, Y.
    Harper, J. C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 (09) : 1063 - 1070
  • [8] Treatment of adult female acne: a new challenge
    Dreno, B.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 : 14 - 19
  • [9] Adult female acne: a guide to clinical practice
    Bagatin, Edileia
    Proenca de Freitas, Thais Helena
    Rivitti Machado, Maria Cecilia
    Ribeiro, Beatriz Medeiros
    Nunes, Samanta
    Dias da Rocha, Marco Alexandre
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2019, 94 (01) : 62 - 75
  • [10] Evaluating and Treating the Adult Female Patient With Acne
    Zeichner, Joshua A.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2013, 12 (12) : 1418 - 1427